Bio-Bridge Science Announces Increase of $1.45 Million to Private Placement
July 11 2008 - 8:18AM
Business Wire
Bio-Bridge Science, Inc. (OTCBB:BGES), a biotechnology company
engaged in the commercial development of vaccines for the
prevention and treatment of human infectious diseases announced
today that it had increased the size of its private placement by
closing a sale of additional investment units. Each investment unit
consists of a share of common stock, two series of common stock
purchase warrants to purchase 0.5 share of common stock
respectively. The offering of $1,450,000 of investment units was
purchased by a director, Mr. Cheung Hin Shun Anthony. The Company
will receive total proceeds of $ 1.45 million. $120,000 was paid at
closing, and the balance of $1.33 million will be paid in ten equal
amounts in monthly installments until May 31, 2009. The proceeds
will be used for general working capital purpose and to fund our
vaccine development activities in China. Dr. Liang Qiao, Chairman
and CEO of Bio-Bridge said, �We are happy to see our directors show
a strong support for our company and have confidence in our
business and strategy. We closed private placements for a total
$4.23 million recently, including Mr. Cheung�s investment. We
expect that these funds will assist us in both our core business of
vaccine development and in plans for our acquisitions/joint
ventures. We are optimistic that our continuous hard work will
begin to demonstrate results.� This press release contains
forward-looking statements. Forward-looking statements include
statements concerning plans, objectives, goals, strategies, future
events or performance, and underlying assumptions and other
statements that are other than statements of historical facts.
These statements are subject to uncertainties and risks including,
but not limited to, product and service demand and acceptance,
changes in technology, economic conditions, the impact of
competition and pricing, government regulation, and other risks
defined in this document and in statements filed from time to time
with the Securities and Exchange Commission. All such
forward-looking statements, whether written or oral, and whether
made by or on behalf of the company, are expressly qualified by
these cautionary statements and any other cautionary statements
which may accompany the forward-looking statements. In addition,
the company disclaims any obligation to update any forward-looking
statements to reflect events or circumstances after the date
hereof. Please refer to the Company's SEC filings for additional
information.
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bio Bridge Science Inc (CE) (OTCMarkets): 0 recent articles
More Bio-Bridge Science, Inc. News Articles